The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.50
Ask: 45.00
Change: -3.25 (-6.77%)
Spread: 0.50 (1.124%)
Open: 44.60
High: 46.00
Low: 44.60
Prev. Close: 48.00
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

14 Aug 2019 07:00

RNS Number : 9496I
Benchmark Holdings PLC
14 August 2019
 

Benchmark Holdings plc

("Benchmark" or the "Company") 

Directorate Change 

Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, is pleased to announce the appointment of Septima Maguire as Chief Financial Officer. Septima is expected to commence her new role in November. Mark Plampin will remain with the business until January to ensure an effective transition.

Septima joins Benchmark from Dechra Pharmaceuticals PLC, the FTSE 250 international provider of specialist veterinary pharmaceuticals and related products, where she spent four years. Having joined as Group Financial Controller she was Acting Group Finance Director between 2016 and 2017. She was most recently Corporate Development Director overseeing all aspects of acquisition activities, strategic projects, business development and investment initiatives playing a significant role in supporting the company during a period of high growth.

 

Previously, Septima held a number of senior finance roles at Ardagh Group S.A., the international packaging manufacturer with revenues of €9.1bn, over a period of six years. She has also held finance roles at Impress Global, CHN Capital and PricewaterhouseCoopers. Septima holds a Masters in European Union Law from the University of Leicester and is ACCA qualified.

 

Malcolm Pye, Benchmark CEO commented: 

"We are delighted to have recruited someone of Septima's calibre. She has extensive strategic, investor and operational finance experience and proven expertise in driving improved business performance. She will be a valuable member of the leadership team as we focus on implementing structural and operational efficiencies and delivering on our five year strategy to drive future growth and profitability."

Peter George, Chairman commented:

"As Benchmark grows and moves from R&D spend to profit generating we need to balance our skill mix. Septima is an excellent addition to the management team and the Board is very pleased to announce this appointment."

 

The following information regarding the appointment of Septima Maguire, aged 42, is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM rules.

 

Current Directorships:

Dechra Finance Ireland DAC

  -ENDS-

 

 Enquiries:

 

Benchmark Holdings plc

Tel: 020 3915 1236

Malcolm Pye, CEO

 

Mark Plampin, CFO

 

Ivonne Cantu, Investor Relations

 

Numis (Broker and NOMAD)

Tel: 020 7260 1000

James Black, Freddie Barnfield, Freddie Naylor-Leyland

 

MHP Communications

Tel: 020 3128 8742

Katie Hunt / Reg Hoare / Alistair de Kare-Silver benchmark@mphc.com

 

 About Benchmark Benchmark's mission is to enable food producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), sea lice treatments, training and data management tools. Find out more at www.benchmarkplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADDGDIDGBBGCX
Date   Source Headline
31st Jan 20242:03 pmRNSForm 8.3 - Benchmark Holdings
31st Jan 20247:00 amRNSTotal Voting Rights
30th Jan 202411:38 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
29th Jan 202412:18 pmRNSForm 8.3 - Benchmark Holdings plc
26th Jan 20243:19 pmRNSForm 8.3 - Benchmark Holdings Plc - Replacement
26th Jan 202410:48 amRNSForm 8.3 - Benchmark Holdings
26th Jan 20247:00 amRNSForm 8 (OPD) (Benchmark Holdings PLC)
24th Jan 20243:37 pmRNSForm 8.3 - Benchmark Holdings plc - Amendment
24th Jan 20248:46 amRNSForm 8.3 - Benchmark Holdings plc
23rd Jan 20242:40 pmRNSForm 8.3 - Benchmark Holdings Plc
23rd Jan 20242:25 pmRNSForm 8.3 - Benchmark Holdings Plc-Replacement
23rd Jan 20241:57 pmGNWForm 8.3 - [BENCHMARK HOLDINGS PLC - Opening Disclosure - 22 01 2024] - (CGAML)
23rd Jan 202411:20 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
23rd Jan 20247:00 amRNSNotice of Q1 Results
22nd Jan 20246:02 pmRNSRule 2.9 Announcement
22nd Jan 20245:14 pmRNSForm 8.3 - Benchmark Holdings Plc-Replacement
22nd Jan 20244:27 pmRNSForm 8.3 - Benchmark Holdings Plc
22nd Jan 20241:48 pmRNSForm 8.3 -Benchmark Holdings Plc
22nd Jan 20247:00 amRNSStrategic Review and Formal Sale Process
16th Jan 20245:30 pmRNSNotice of AGM - correction
9th Jan 20245:15 pmRNSPosting of Notice of AGM
12th Dec 20235:50 pmRNSNew Long Term Incentive Plan and PDMR Dealing
12th Dec 20231:54 pmRNSDirectorate Change
7th Dec 202312:00 pmRNSPublication of Annual Report and Notice of AGM
29th Nov 20237:01 amRNSDirectorate Change
29th Nov 20237:01 amRNSQ4 Results
29th Nov 20237:00 amRNSFull Year Results
6th Nov 202310:24 amRNSNotice of Q4 and Full Year Results
31st Oct 20237:00 amRNSTotal Voting Rights
10th Oct 202311:26 amRNSNew salmon broodstock licenses - correction
10th Oct 202310:06 amRNSGrant of two new salmon broodstock licenses
29th Sep 20237:00 amRNSTotal Voting Rights
21st Sep 20237:00 amRNSBlock Listing Six Monthly Return
31st Aug 20237:00 amRNSTotal Voting Rights
24th Aug 20237:00 amRNSQ3 Results
11th Aug 20237:00 amRNSNotice of Q3 Results
31st Jul 20237:00 amRNSTotal Voting Rights
30th Jun 20237:00 amRNSAppointment of Non-Executive Director
30th Jun 20237:00 amRNSTotal Voting Rights
31st May 20237:00 amRNSTotal Voting Rights
30th May 20233:30 pmRNSPCA Shareholding
30th May 202311:55 amRNSHolding(s) in Company
23rd May 20237:00 amRNSSecond Quarter and Interim results
5th May 20237:00 amRNSNotice of Q2 and Interim Results
28th Apr 20237:00 amRNSTotal Voting Rights
21st Apr 20231:00 pmRNSDirector Share Options
17th Apr 20237:00 amRNSDirectorate Change
12th Apr 20237:00 amRNSListing of Green NOK Bond
31st Mar 20237:00 amRNSTotal Voting Rights
21st Mar 20235:33 pmRNSShare Premium Reduction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.